Study of Efficacy and Safety of Reinfusion of Tisagenlecleucel in Pediatric and Young Adult Patients With Acute Lymphoblastic Leukemia (ALL)
Clinical trial NCT04225676 · TERMINATED
Trial details
- NCT number
- NCT04225676
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-19
- Primary completion
- 2021-10-19
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.